Comparative Tolerability of Sedative Agents in Head-Injured Adults

Authors: Urwin, Susan C.1; Menon, David K.2

Source: Drug Safety, Volume 27, Number 2, 2004 , pp. 107-133(27)

Publisher: Adis International

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

Sedative agents are widely used in the management of patients with head injury. These drugs can facilitate assisted ventilation and may provide useful reductions in cerebral oxygen demand. However, they may compromise cerebral oxygen delivery via their cardiovascular effects. In addition, individual sedative agents have specific and sometimes serious adverse effects. This review focuses on the different classes of sedative agents used in head injury, with a discussion of their role in the context of clinical pathophysiology. While there is no sedative that has all the desirable characteristics for an agent in this clinical setting, careful titration of dose, combination of agents, and a clear understanding of the pathophysiology and pharmacology of these agents will allow safe sedative administration in head injury.

Keywords: Head injuries, treatment; Benzodiazepines, therapeutic use; Benzodiazepines, adverse reactions; Propofol, adverse reactions; Propofol, therapeutic use; Opioids, therapeutic use; Opioids, adverse reactions; Barbiturates, adverse reactions; Barbiturates, therapeutic use; Ketamine, therapeutic use; Ketamine, adverse reactions; Etomidate, adverse reactions; Etomidate, therapeutic use; Alpha 2 adrenoceptor antagonists, therapeutic use; Alpha 2 adrenoceptor antagonists, adverse reaction; Antipsychotics, adverse reactions; Antipsychotics, therapeutic use

Document Type: Review article

Affiliations: 1: 1 Department of Anaesthesia, Addenbrooke's Hospital, Cambridge, United Kingdom 2: 2 Department of Anaesthesia, University of Cambridge, Addenbrooke's Hospital, Cambridge, United Kingdom

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$62.95 plus tax      Refund Policy

 

OR

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A